Codon

AUGUST 10, 2023

Philosophical Transactions of the Royal Society B (2016). Link →A Brief History of De Novo Protein Design: Minimal, Rational, and Computational , by Woolfson D.N. Link The coming of age of de novo protein design , by Huang P-S. Nature (2016). Science (2016). Nature (2016). & Charpentier E.

DNA 98

DNA Cell Biology Molecular Biology Engineering 98

Sygnature Discovery

APRIL 26, 2022

Sygnature have acquired Peak Proteins Ltd. Following an extensive partnership between the two companies, this deal will enable seamless integration of protein production and related structure determination projects within Sygnature. The Peak Proteins leadership team will also remain with the business.

Fragment Screening 52

Fragment Screening Protein Production Protein Expression Production 52

Codon

AUGUST 10, 2023

Philosophical Transactions of the Royal Society B (2016). Link →A Brief History of De Novo Protein Design: Minimal, Rational, and Computational , by Woolfson D.N. Link The coming of age of de novo protein design , by Huang P-S. Nature (2016). Science (2016). Nature (2016). Cell (2016).

DNA 52

DNA Cell Biology Engineering Molecular Biology 52

The Pharma Data

DECEMBER 22, 2020

Using the obtained sequencing data, Kao Corporation was able to produce an antibody sample in one week using protein production technology such as enzymes cultivated by our technology. Comment from Fumiharu Muroga, Growth Manager at Real Tech Fund] “Proteins are an important structural component of living things.

Engineering 52

Engineering Pharmaceuticals Protein Production International 52

Codon

MARCH 24, 2024

In 2012, an Israeli company called Protalix gained approval for their plant-based enzyme product for Gaucher’s disease. In 2016, a company called Synageva BioPharma (formerly AviGenics) was acquired by Alexion for $8.4B. Tiamat Sciences harvests a variety of protein products in tobacco plants.

Engineering 87

Engineering Vaccine Production RNA 87

Drug Target Review

JULY 5, 2023

5 And for the latter, the development of a technique to temporally track gene expression in CHO cells, which therefore has the potential to lead to the identification of targets to improve recombinant protein production. 2016), 32: 1301-1307 Matasci M, Baldo L, et al. 2007), 103(7): 40–47. Rajendra Y, Peery RB, Barnard GC.

Engineering 105

Engineering DNA Laboratories Production 105

The Pharma Data

JANUARY 24, 2021

” About Elasmogen: Spun-out from the University of Aberdeen, Scotland in 2016, Elasmogen is developing soloMERs ; fully humanized (or de-immunised) VNAR, as next generation, single chain therapeutics for auto-inflammatory diseases, oncology and intracellular delivery.

Research 52

Research Virus Medical Schools Government 52